Inogen (INGN) - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US45780L1044
Inogen, Inc. is a reputable medical technology company listed on the NASDAQ under the ticker symbol INGN. Operating both in the United States and globally, they focus on developing, producing, and distributing innovative portable oxygen concentrators.
Specializing in enhancing the quality of life for patients with chronic respiratory conditions, Inogen's oxygen concentrators are designed to provide long-term oxygen therapy efficiently. Their flagship product, the Inogen One, is a portable device that concentrates surrounding air into a convenient source of supplemental oxygen.
In addition to their portable devices, Inogen also offers stationary oxygen concentrators under the name Inogen At Home, along with a variety of complementary accessories that cater to the diverse needs of their users.
Furthermore, Inogen operates by directly renting out their products to patients, offering a flexible solution that aligns with individual healthcare requirements. Established in 2001, the company is headquartered in Goleta, California, and continues to spearhead advancements in the field of respiratory care. For more information, visit their official website at https://www.inogen.com.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
INGN Stock Overview
Market Cap in USD | 177m |
Sector | Healthcare |
Industry | Medical Devices |
GiC SubIndustry | Health Care Equipment |
TER | 0.00% |
IPO / Inception | 2014-02-14 |
INGN Stock Ratings
Fundamental | -6.84 |
Dividend | - |
Growth 5y | -6.09 |
Rel. Performance vs Sector | -6.15 |
Analysts | 3.25/5 |
Fair Price Momentum | 7.11 USD |
Fair Price DCF | - |
INGN Dividends
Yield 12m | 0.00% |
Yield on Cost 5y | 0.00% |
Dividends CAGR 5y | 0.00% |
Payout Consistency | 0.0% |
INGN Growth Ratios
Growth 12m | -32.95% |
Growth Correlation 12m | -40% |
Growth Correlation 3m | 43% |
CAGR 5y | -38.55% |
Sharpe Ratio 12m | -0.51 |
Alpha vs SP500 12m | -62.75 |
Beta vs SP500 5y weekly | 0.91 |
ValueRay RSI | 89.68 |
Volatility GJR Garch 1y | 54.17% |
Price / SMA 50 | 9.33% |
Price / SMA 200 | 17.21% |
Current Volume | 242.4k |
Average Volume 20d | 391.8k |
External Links for INGN Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X (Twitter) • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of March 29, 2024, the stock is trading at USD 7.97 with a total of 242,350 shares traded.
Over the past week, the price has changed by +15.60%, over one month by -14.72%, over three months by +42.61% and over the past year by -35.40%.
According to ValueRays Forecast Model, INGN Inogen will be worth about 7.9 in March 2025. The stock is currently trading at 7.97. This means that the stock has a potential downside of -1.51%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 6.5 | -18.4% |
Analysts Target Price | 8 | 0.38% |
ValueRay Target Price | 7.9 | -1.51% |